Results 81 to 90 of about 1,252 (192)
The p38–PGC-1α–irisin–betatrophin axis [PDF]
Adipocyte, 2013 The discovery of irisin as a novel and promising peptidic hormone has raised hopes regarding the hypothesis that irisin may provide additional benefits, not only for obesity and diabetes, but also for a wide range of pathological conditions since this hormone may prove to be therapeutically and clinically beneficial.
Fabian, Sanchis-Gomar +1 more
openaire +2 more sources
Türk Biyokimya Dergisi, 2021 The number of studies examining the circulating level change of betatrophin and cartonectin in metabolic syndrome applying different loads of exercise is limited.
Karaman Muhammed Emre +2 more
doaj +1 more source
ANGPTL8 in metabolic homeostasis: more friend than foe?
Open Biology, 2021 ANGPTL8 is an important cytokine, which is significantly increased in type 2 diabetes mellitus (T2DM), obesity and metabolic syndrome. Many studies have shown that ANGPTL8 can be used as a bio-marker of these metabolic disorders related diseases, and the
Chang Guo +5 more
doaj +1 more source
Chronic Diseases Journal, 2023 BACKGROUND: Angiopoietin-like protein 8 (ANGPTL8) that was originally called betatrophin is a novel growth factor which is mainly secreted by the liver and associated with diabetes. Hence, it can be considered as a clinical parameter for diagnosis or treatment of diabetes.
Vakili, Nadia +6 more
openaire +1 more source
PLoS ONE, 2017 ObjectiveThe association between circulating betatrophin levels and gestational diabetes mellitus (GDM) is controversial. The aim of our study was to systematically review available literature linking betatrophin to GDM for a comprehensive understanding ...
Fei-Juan Kong +4 more
doaj +1 more source
Weight Loss Partially Restores Glucose-Driven Betatrophin Response in Humans [PDF]
The Journal of Clinical Endocrinology & Metabolism, 2016 Recently a potential role of betatrophin was shown in the postprandial switch from lipid to glucose metabolism.The objective of the study was to analyze whether obesity is associated with altered postprandial betatrophin response and whether this could be restored by weight loss.
Lukas, Maurer +10 more
openaire +2 more sources
Circulating Betatrophin in Patients with Type 2 Diabetes: A Meta-Analysis
Journal of Diabetes Research, 2016 Objective. To investigate the association between circulating betatrophin level and type 2 diabetes mellitus (T2DM) in human. Methods. A comprehensive literature search was performed in PubMed and Embase databases to identify eligible studies assessing ...
Sheyu Li +7 more
doaj +1 more source
Managing diabetes with nanomedicine: challenges and opportunities [PDF]
, 2014 Nanotechnology-based approaches hold substantial potential for improving the care of patients with diabetes. Nanoparticles are being developed as imaging contrast agents to assist in the early diagnosis of type 1 diabetes.
Anderson, Daniel Griffith +4 more
core +1 more source
Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism [PDF]
BioMed Research International, 2016 Thyroid hormone (TH) affects many metabolic processes such as promoting oxidation of sugar, fat, and protein in many tissues. Thyroid dysfunction is associated with metabolic disorders. The newly discovered adipocyte- and hepatocyte-derived cytokine, betatrophin, has been reported to be involved in metabolic diseases, but its influence on thyroid ...
Han, Cheng +10 more
openaire +2 more sources
Angiopoietin-like 8 (Angptl8) controls adipocyte lipolysis and phospholipid composition [PDF]
, 2017 Angiopoietin-like 8 (Angptl8) inhibits lipolysis in the circulation together with Angplt3 and controls post-prandial fat storage in white adipose tissue (WAT). It is strongly induced by insulin in vivo in WAT and in vitro in adipocytes.
Haridas, P. A. Nidhina +4 more
core +3 more sources